233 related articles for article (PubMed ID: 25744480)
41. Predicting axillary sentinel node status in patients with primary breast cancer.
Kolarik D; Pecha V; Skovajsova M; Zahumensky J; Trnkova M; Petruzelka L; Halaska M; Sottner O; Otcenasek M; Kolarova H
Neoplasma; 2013; 60(3):334-42. PubMed ID: 23374005
[TBL] [Abstract][Full Text] [Related]
42. Factors that predict the burden of axillary disease in breast cancer patients with a positive sentinel node.
Beriwal S; Soran A; Kocer B; Wilson JW; Ahrendt GM; Johnson R
Am J Clin Oncol; 2008 Feb; 31(1):34-8. PubMed ID: 18376225
[TBL] [Abstract][Full Text] [Related]
43. Three-axillary lymph node sampling for the prediction of nonsentinel node metastases in breast cancer patients with sentinel node metastases.
Motomura K; Egawa C; Komoike Y; Nagumo S; Koyama H; Inaji H
Ann Surg Oncol; 2006 Jul; 13(7):985-9. PubMed ID: 16788761
[TBL] [Abstract][Full Text] [Related]
44. Axillary sentinel lymph node micrometastases with extracapsular extension: a distinct pattern of breast cancer metastasis?
Cserni G
J Clin Pathol; 2008 Jan; 61(1):115-8. PubMed ID: 17468292
[TBL] [Abstract][Full Text] [Related]
45. Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.
Hatoum HA; Jamali FR; El-Saghir NS; Musallam KM; Seoud M; Dimassi H; Abbas J; Khalife M; Boulos FI; Tawil AN; Geara FB; Salem Z; Shamseddine AA; Al-Feghali K; Shamseddine AI
Ann Surg Oncol; 2009 Dec; 16(12):3388-95. PubMed ID: 19655200
[TBL] [Abstract][Full Text] [Related]
46. Factors predicting non-sentinel lymph node involvement in sentinel node positive breast carcinoma.
Durak MG; Akansu B; Akin MM; Sevınç AI; Koçdor MA; Saydam S; Harmancioğlu O; Ellıdokuz H; Bekış R; Canda T
Turk Patoloji Derg; 2011; 27(3):189-95. PubMed ID: 21935867
[TBL] [Abstract][Full Text] [Related]
47. Ultrasound elastography as an adjuvant to conventional ultrasound in the preoperative assessment of axillary lymph nodes in suspected breast cancer: a pilot study.
Taylor K; O'Keeffe S; Britton PD; Wallis MG; Treece GM; Housden J; Parashar D; Bond S; Sinnatamby R
Clin Radiol; 2011 Nov; 66(11):1064-71. PubMed ID: 21835398
[TBL] [Abstract][Full Text] [Related]
48. Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis.
Shao GL; Wang MC; Fan XL; Zhong L; Ji SF; Sang G; Wang S
Technol Cancer Res Treat; 2018 Jan; 17():1533034617754024. PubMed ID: 29529946
[TBL] [Abstract][Full Text] [Related]
49. The effects of ECE on the benefits of PMRT for breast cancer patients with positive axillary nodes.
Geng W; Zhang B; Li D; Liang X; Cao X
J Radiat Res; 2013 Jul; 54(4):712-8. PubMed ID: 23392824
[TBL] [Abstract][Full Text] [Related]
50. Measurement of extracapsular extension in sentinel lymph node as a possible predictor of residual axillary disease in breast cancer.
Freitas GB; Mota BS; Maesaka JY; Pinheiro CC; de Lima LGCA; Soares JM; Baracat EC; Filassi JR
Clinics (Sao Paulo); 2023; 78():100216. PubMed ID: 37201303
[TBL] [Abstract][Full Text] [Related]
51. Dual-modal computer-assisted evaluation of axillary lymph node metastasis in breast cancer patients on both real-time elastography and B-mode ultrasound.
Zhang Q; Suo J; Chang W; Shi J; Chen M
Eur J Radiol; 2017 Oct; 95():66-74. PubMed ID: 28987700
[TBL] [Abstract][Full Text] [Related]
52. Prevalence of extracapsular extension in metastatic sentinel lymph nodes in breast cancer.
Layse de Menezes Dantas M; Hugo da Silva Santos Y; Alcântara da Silva PH; Medeiros de Azevedo F; Petta TB; Sampaio Marinho Navarro DT
Surg Oncol; 2021 Sep; 38():101594. PubMed ID: 33930842
[TBL] [Abstract][Full Text] [Related]
53. Prognostic value of extranodal extension in axillary lymph node-positive breast cancer.
Ma X; Yang X; Yang W; Shui R
Sci Rep; 2021 May; 11(1):9534. PubMed ID: 33953240
[TBL] [Abstract][Full Text] [Related]
54. Dynamic contrast enhanced MRI of the axilla in women with breast cancer: comparison with pathology of excised nodes.
Murray AD; Staff RT; Redpath TW; Gilbert FJ; Ah-See AK; Brookes JA; Miller ID; Payne S
Br J Radiol; 2002 Mar; 75(891):220-8. PubMed ID: 11932214
[TBL] [Abstract][Full Text] [Related]
55. The value of T2* in differentiating metastatic from benign axillary lymph nodes in patients with breast cancer--a preliminary in vivo study.
Li C; Meng S; Yang X; Wang J; Hu J
PLoS One; 2014; 9(1):e84038. PubMed ID: 24454715
[TBL] [Abstract][Full Text] [Related]
56. Differentiation of benign and metastatic axillary lymph nodes in breast cancer: additive value of MRI computer-aided evaluation.
Yun SJ; Sohn YM; Seo M
Clin Radiol; 2016 Apr; 71(4):403.e1-7. PubMed ID: 26875621
[TBL] [Abstract][Full Text] [Related]
57. Integrative 3' Untranslated Region-Based Model to Identify Patients with Low Risk of Axillary Lymph Node Metastasis in Operable Triple-Negative Breast Cancer.
Wang L; Hu X; Wang P; Shao ZM
Oncologist; 2019 Jan; 24(1):22-30. PubMed ID: 30082491
[TBL] [Abstract][Full Text] [Related]
58. A nomogram to predict the probability of axillary lymph node metastasis in early breast cancer patients with positive axillary ultrasound.
Qiu SQ; Zeng HC; Zhang F; Chen C; Huang WH; Pleijhuis RG; Wu JD; van Dam GM; Zhang GJ
Sci Rep; 2016 Feb; 6():21196. PubMed ID: 26875677
[TBL] [Abstract][Full Text] [Related]
59. Axillary lymph node metastasis detection by magnetic resonance imaging in patients with breast cancer: A meta-analysis.
Zhou P; Wei Y; Chen G; Guo L; Yan D; Wang Y
Thorac Cancer; 2018 Aug; 9(8):989-996. PubMed ID: 29877048
[TBL] [Abstract][Full Text] [Related]
60. Quantitative ultrasound image analysis of axillary lymph node status in breast cancer patients.
Drukker K; Giger M; Meinel LA; Starkey A; Janardanan J; Abe H
Int J Comput Assist Radiol Surg; 2013 Nov; 8(6):895-903. PubMed ID: 23526445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
